"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
Descriptor ID |
D009367
|
MeSH Number(s) |
E01.789.625
|
Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 10 | 10 |
1996 | 0 | 11 | 11 |
1997 | 1 | 16 | 17 |
1998 | 1 | 17 | 18 |
1999 | 2 | 15 | 17 |
2000 | 0 | 31 | 31 |
2001 | 1 | 20 | 21 |
2002 | 0 | 13 | 13 |
2003 | 2 | 22 | 24 |
2004 | 2 | 17 | 19 |
2005 | 2 | 32 | 34 |
2006 | 0 | 32 | 32 |
2007 | 2 | 46 | 48 |
2008 | 2 | 56 | 58 |
2009 | 1 | 42 | 43 |
2010 | 2 | 62 | 64 |
2011 | 4 | 52 | 56 |
2012 | 2 | 57 | 59 |
2013 | 4 | 62 | 66 |
2014 | 4 | 76 | 80 |
2015 | 2 | 67 | 69 |
2016 | 11 | 57 | 68 |
2017 | 4 | 68 | 72 |
2018 | 4 | 54 | 58 |
2019 | 10 | 56 | 66 |
2020 | 2 | 44 | 46 |
2021 | 1 | 37 | 38 |
2022 | 0 | 24 | 24 |
2023 | 1 | 22 | 23 |
2024 | 18 | 28 | 46 |
2025 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer. Breast Cancer Res Treat. 2025 May; 211(1):111-119.
-
Preoperative Chest CT Myosteatosis Indicates Worse Postoperative Survival in Stage 0-IIB Non-Small Cell Lung Cancer. Radiology. 2025 Feb; 314(2):e240282.
-
Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adults. Blood Adv. 2025 Jan 28; 9(2):280-290.
-
The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer. Ann Thorac Surg. 2025 Mar; 119(3):495-508.
-
How to Predict Recurrence After Resection of Hepatocellular Carcinoma. Anticancer Res. 2025 Jan; 45(1):189-199.
-
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour. BJU Int. 2025 Apr; 135(4):621-628.
-
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer. Breast Cancer Res Treat. 2025 Feb; 209(3):487-492.
-
Social vulnerability is associated with advanced breast cancer presentation and all-cause mortality: a retrospective cohort study. Breast Cancer Res. 2024 Dec 03; 26(1):176.
-
Proposed Ninth Edition TNM Staging System for Lung Cancer: Guide for Radiologists. Radiographics. 2024 12; 44(12):e240057.
-
American College of Surgeons survival calculator for biliary tract cancers: using machine learning to individualize predictions. Surgery. 2025 02; 178:108919.